Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.
Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, De Leyn PR, De Wever W, Verbeken EK, Gatti GG, Huyskens DP, Kutcher GJ. Vanuytsel LJ, et al. Among authors: vansteenkiste jf. Radiother Oncol. 2000 Jun;55(3):317-24. doi: 10.1016/s0167-8140(00)00138-9. Radiother Oncol. 2000. PMID: 10869746
Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine.
Vansteenkiste JF, Vandebroek JE, Nackaerts KL, Weynants P, Valcke YJ, Verresen DA, Devogelaere RC, Marien SA, Humblet YP, Dams NL; Leuven Lung Cancer Group. Vansteenkiste JF, et al. Ann Oncol. 2001 Sep;12(9):1221-30. doi: 10.1023/a:1012208711013. Ann Oncol. 2001. PMID: 11697832 Clinical Trial.
Broncholithiasis: rare but still present.
Nollet AS, Vansteenkiste JF, Demedts MG. Nollet AS, et al. Among authors: vansteenkiste jf. Respir Med. 1998 Jul;92(7):963-5. doi: 10.1016/s0954-6111(98)90197-4. Respir Med. 1998. PMID: 10070571
69 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page